1332 related articles for article (PubMed ID: 19289371)
41. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
[TBL] [Abstract][Full Text] [Related]
42. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
43. Exosomal microRNAs as tumor markers in epithelial ovarian cancer.
Pan C; Stevic I; Müller V; Ni Q; Oliveira-Ferrer L; Pantel K; Schwarzenbach H
Mol Oncol; 2018 Nov; 12(11):1935-1948. PubMed ID: 30107086
[TBL] [Abstract][Full Text] [Related]
44. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer.
Wu J; Shen Z
Cancer Med; 2020 Oct; 9(19):6909-6922. PubMed ID: 32779402
[TBL] [Abstract][Full Text] [Related]
45. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
[TBL] [Abstract][Full Text] [Related]
46. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
47. No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People.
Tian F; Shen Y; Chen Z; Li R; Ge Q
Biomed Res Int; 2017; 2017():1304816. PubMed ID: 28656135
[TBL] [Abstract][Full Text] [Related]
48. [Detection of plasma cofilin protein for diagnosis of lung cancer].
Zheng Y; Fang Y; Li S; Zheng B
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1551-3. PubMed ID: 24144768
[TBL] [Abstract][Full Text] [Related]
49. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
Kamimura A; Kamachi M; Nishihira J; Ogura S; Isobe H; Dosaka-Akita H; Ogata A; Shindoh M; Ohbuchi T; Kawakami Y
Cancer; 2000 Jul; 89(2):334-41. PubMed ID: 10918163
[TBL] [Abstract][Full Text] [Related]
50. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis.
Yamashita T; Kamada H; Kanasaki S; Maeda Y; Nagano K; Abe Y; Inoue M; Yoshioka Y; Tsutsumi Y; Katayama S; Inoue M; Tsunoda S
Pharmazie; 2013 Dec; 68(12):969-73. PubMed ID: 24400444
[TBL] [Abstract][Full Text] [Related]
51. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
[TBL] [Abstract][Full Text] [Related]
52. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
Ikehara M; Oshita F; Kameda Y; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A
Oncol Rep; 2002; 9(4):835-8. PubMed ID: 12066218
[TBL] [Abstract][Full Text] [Related]
53. Stability of Circulating Exosomal miRNAs in Healthy Subjects.
Sanz-Rubio D; Martin-Burriel I; Gil A; Cubero P; Forner M; Khalyfa A; Marin JM
Sci Rep; 2018 Jul; 8(1):10306. PubMed ID: 29985466
[TBL] [Abstract][Full Text] [Related]
54. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
Haga E
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.
Ahmed FE; Amed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Allison RR
Cancer Genomics Proteomics; 2012; 9(4):179-92. PubMed ID: 22798503
[TBL] [Abstract][Full Text] [Related]
56. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer.
Samsonov R; Burdakov V; Shtam T; Radzhabovа Z; Vasilyev D; Tsyrlina E; Titov S; Ivanov M; Berstein L; Filatov M; Kolesnikov N; Gil-Henn H; Malek A
Tumour Biol; 2016 Sep; 37(9):12011-12021. PubMed ID: 27164936
[TBL] [Abstract][Full Text] [Related]
57. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts.
Yang F; Ning Z; Ma L; Liu W; Shao C; Shu Y; Shen H
Mol Cancer; 2017 Aug; 16(1):148. PubMed ID: 28851377
[TBL] [Abstract][Full Text] [Related]
58. Role of exosomal microRNAs in lung cancer biology and clinical applications.
Hu C; Meiners S; Lukas C; Stathopoulos GT; Chen J
Cell Prolif; 2020 Jun; 53(6):e12828. PubMed ID: 32391938
[TBL] [Abstract][Full Text] [Related]
59. In situ single step detection of exosome microRNA using molecular beacon.
Lee JH; Kim JA; Kwon MH; Kang JY; Rhee WJ
Biomaterials; 2015 Jun; 54():116-25. PubMed ID: 25907045
[TBL] [Abstract][Full Text] [Related]
60. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Schwarzenbach H
Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
